News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
650,263 Results
Type
Article (40874)
Company Profile (159)
Press Release (609221)
Multimedia
Podcasts (67)
Webinars (11)
Section
Business (175588)
Career Advice (2806)
Deals (35052)
Drug Delivery (100)
Drug Development (73561)
Employer Resources (161)
FDA (15897)
Job Trends (14889)
News (307469)
Policy (29897)
Tag
Academia (2722)
Academic (1)
Accelerated approval (14)
Adcomms (27)
Allergies (124)
Alliances (44276)
ALS (140)
Alzheimer's disease (1607)
Antibody-drug conjugate (ADC) (219)
Approvals (16020)
Artificial intelligence (442)
Autoimmune disease (91)
Automation (28)
Bankruptcy (301)
Best Places to Work (12171)
BIOSECURE Act (19)
Biosimilars (149)
Biotechnology (109)
Bladder cancer (133)
Brain cancer (48)
Breast cancer (498)
Cancer (3888)
Cardiovascular disease (315)
Career advice (2348)
Career pathing (37)
CAR-T (231)
CDC (39)
Cell therapy (645)
Cervical cancer (30)
Clinical research (62171)
Collaboration (1361)
Company closure (3)
Compensation (930)
Complete response letters (45)
COVID-19 (2603)
CRISPR (77)
C-suite (596)
Cystic fibrosis (136)
Data (4747)
Decentralized trials (1)
Denatured (15)
Depression (95)
Diabetes (419)
Diagnostics (6836)
Digital health (36)
Diversity (9)
Diversity, equity & inclusion (40)
Drug discovery (207)
Drug pricing (142)
Drug shortages (24)
Duchenne muscular dystrophy (182)
Earnings (71546)
Editorial (49)
Employer branding (21)
Employer resources (145)
Events (106209)
Executive appointments (980)
FDA (18405)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (16)
Funding (1222)
Gene editing (164)
Generative AI (38)
Gene therapy (491)
GLP-1 (826)
Government (4312)
Grass and pollen (7)
Guidances (367)
Healthcare (20021)
HIV (44)
Huntington's disease (36)
IgA nephropathy (60)
Immunology and inflammation (205)
Immuno-oncology (14)
Indications (58)
Infectious disease (2831)
Inflammatory bowel disease (184)
Inflation Reduction Act (11)
Influenza (96)
Intellectual property (195)
Interviews (554)
IPO (16413)
IRA (44)
Job creations (3098)
Job search strategy (1925)
Kidney cancer (17)
Labor market (60)
Layoffs (522)
Leadership (35)
Legal (6760)
Liver cancer (78)
Longevity (11)
Lung cancer (547)
Lymphoma (256)
Machine learning (30)
Management (61)
Manufacturing (598)
MASH (138)
Medical device (14353)
Medtech (14379)
Mergers & acquisitions (19644)
Metabolic disorders (998)
Multiple sclerosis (131)
NASH (13)
Neurodegenerative disease (214)
Neuropsychiatric disorders (55)
Neuroscience (2597)
NextGen: Class of 2025 (6848)
Non-profit (4873)
Now hiring (48)
Obesity (441)
Opinion (269)
Ovarian cancer (139)
Pain (165)
Pancreatic cancer (169)
Parkinson's disease (238)
Partnered (27)
Patents (408)
Patient recruitment (332)
Peanut (55)
People (53275)
Pharmaceutical (43)
Pharmacy benefit managers (24)
Phase I (19353)
Phase II (27501)
Phase III (20619)
Pipeline (2744)
Policy (228)
Postmarket research (2085)
Preclinical (7975)
Press Release (62)
Prostate cancer (194)
Psychedelics (42)
Radiopharmaceuticals (273)
Rare diseases (635)
Real estate (5082)
Recruiting (67)
Regulatory (22198)
Reports (34)
Research institute (2506)
Resumes & cover letters (457)
Rett syndrome (15)
RNA editing (10)
RSV (69)
Schizophrenia (134)
Series A (199)
Series B (151)
Service/supplier (7)
Sickle cell disease (80)
Special edition (19)
Spinal muscular atrophy (149)
Sponsored (32)
Startups (3220)
State (2)
Stomach cancer (8)
Supply chain (93)
Tariffs (72)
The Weekly (51)
Vaccines (867)
Venture capital (55)
Weight loss (281)
Women's health (47)
Worklife (20)
Date
Today (29)
Last 7 days (786)
Last 30 days (2624)
Last 365 days (32102)
2025 (26687)
2024 (36486)
2023 (41508)
2022 (52611)
2021 (57309)
2020 (55873)
2019 (49126)
2018 (37035)
2017 (32623)
2016 (30983)
2015 (36163)
2014 (25447)
2013 (20107)
2012 (21567)
2011 (22414)
2010 (19620)
Location
Africa (804)
Alabama (77)
Alaska (7)
Arizona (207)
Arkansas (12)
Asia (38303)
Australia (6735)
California (9507)
Canada (2885)
China (893)
Colorado (397)
Connecticut (417)
Delaware (267)
Europe (88549)
Florida (1422)
Georgia (318)
Hawaii (2)
Idaho (61)
Illinois (742)
India (47)
Indiana (467)
Iowa (18)
Japan (328)
Kansas (117)
Kentucky (37)
Louisiana (19)
Maine (78)
Maryland (1235)
Massachusetts (7095)
Michigan (307)
Minnesota (553)
Mississippi (3)
Missouri (121)
Montana (32)
Nebraska (26)
Nevada (108)
New Hampshire (78)
New Jersey (2645)
New Mexico (30)
New York (2580)
North Carolina (1331)
North Dakota (10)
Northern California (4433)
Ohio (297)
Oklahoma (21)
Oregon (39)
Pennsylvania (1992)
Puerto Rico (19)
Rhode Island (43)
South America (1136)
South Carolina (50)
South Dakota (1)
Southern California (3687)
Tennessee (149)
Texas (1473)
United States (34747)
Utah (293)
Virginia (235)
Washington D.C. (74)
Washington State (799)
West Virginia (3)
Wisconsin (89)
Wyoming (2)
650,263 Results for "viatris acquired by meda ab".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Viatris to Report Third Quarter 2025 Financial Results on November 6, 2025
October 2, 2025
·
1 min read
Press Releases
Viatris Completes Acquisition of Aculys Pharma Including Exclusive Rights to Pitolisant in Japan and to Spydia® in Japan and Certain Other Markets in the Asia-Pacific Region
October 16, 2025
·
12 min read
Press Releases
Viatris Announces Appointment of David Simmons to the Company’s Board of Directors
August 6, 2025
·
6 min read
Press Releases
Viatris Announces Approval of First Generic Iron Sucrose Injection in the U.S.
August 12, 2025
·
10 min read
Press Releases
Viatris Reports Second Quarter 2025 Results and Reiterates 2025 Financial Guidance
August 7, 2025
·
43 min read
Press Releases
Viatris Provides Update on Phase 3 Study of MR-139 for Blepharitis
July 18, 2025
·
5 min read
Press Releases
AB Science provides intitial Phase 1 data for the combination of AB8939 with venetoclax for the treatment of refractory or relapsed acute myeloid leukemia
October 17, 2025
·
12 min read
Press Releases
Viatris Announces Quarterly Dividend
May 7, 2025
·
3 min read
Press Releases
BioInvent International AB: Interim Report January - September 2025
October 29, 2025
·
3 min read
Press Releases
Notice of Extraordinary General Meeting in Alligator Bioscience AB
October 22, 2025
·
20 min read
1 of 65,027
Next
